These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 28583847

  • 1. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
    Liu SL, Lin HX, Lin CY, Sun XQ, Ye LP, Qiu F, Wen W, Hua X, Wu XQ, Li J, Song LB, Guo L.
    Cancer Lett; 2017 Aug 28; 402():117-130. PubMed ID: 28583847
    [Abstract] [Full Text] [Related]

  • 2. YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway.
    Zhang J, Wen X, Ren XY, Li YQ, Tang XR, Wang YQ, He QM, Yang XJ, Sun Y, Liu N, Ma J.
    J Exp Clin Cancer Res; 2016 Jul 11; 35(1):109. PubMed ID: 27400785
    [Abstract] [Full Text] [Related]

  • 3. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
    Deng YF, Zhou DN, Pan ZY, Yin P.
    Int J Clin Exp Pathol; 2014 Jul 11; 7(5):2454-61. PubMed ID: 24966956
    [Abstract] [Full Text] [Related]

  • 4. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
    Li N, Feng L, Han HQ, Yuan J, Qi XK, Lian YF, Kuang BH, Zhang YC, Deng CC, Zhang HJ, Yao YY, Xu M, He GP, Zhao BC, Gao L, Feng QS, Chen LZ, Yang L, Yang D, Zeng YX.
    Cancer Lett; 2016 Oct 10; 381(1):14-22. PubMed ID: 27424523
    [Abstract] [Full Text] [Related]

  • 5. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
    Zhou XM, Sun R, Luo DH, Sun J, Zhang MY, Wang MH, Yang Y, Wang HY, Mai SJ.
    Oncotarget; 2016 Mar 22; 7(12):13634-50. PubMed ID: 26872369
    [Abstract] [Full Text] [Related]

  • 6. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
    Ren XY, Zhou GQ, Jiang W, Sun Y, Xu YF, Li YQ, Tang XR, Wen X, He QM, Yang XJ, Liu N, Ma J.
    Cancer Prev Res (Phila); 2015 Oct 22; 8(10):968-77. PubMed ID: 26276746
    [Abstract] [Full Text] [Related]

  • 7. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W, Xiao L, Cao C, Hua S, Wu D.
    Oncotarget; 2016 Mar 22; 7(12):15161-72. PubMed ID: 26943030
    [Abstract] [Full Text] [Related]

  • 8. Transducin β-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in nasopharyngeal carcinoma via activation of NF-κB pathway.
    Chen SP, Yang Q, Wang CJ, Zhang LJ, Fang Y, Lei FY, Wu S, Song LB, Guo X, Guo L.
    Mol Cancer; 2014 Aug 22; 13():195. PubMed ID: 25145705
    [Abstract] [Full Text] [Related]

  • 9. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
    Wang W, Yi M, Chen S, Li J, Zhang H, Xiong W, Li G, Li X, Xiang B.
    J Cell Physiol; 2017 Oct 22; 232(10):2829-2840. PubMed ID: 27891591
    [Abstract] [Full Text] [Related]

  • 10. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
    Chang PY, Wu ZZ, Sun NK, Chao CC.
    J Cell Physiol; 2014 Mar 22; 229(3):309-22. PubMed ID: 23939952
    [Abstract] [Full Text] [Related]

  • 11. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
    Bissey PA, Teng M, Law JH, Shi W, Bruce JP, Petit V, Tsao SW, Yip KW, Liu FF.
    BMC Cancer; 2020 Jun 26; 20(1):597. PubMed ID: 32586280
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma.
    Cao JY, Liu L, Chen SP, Zhang X, Mi YJ, Liu ZG, Li MZ, Zhang H, Qian CN, Shao JY, Fu LW, Xia YF, Zeng MS.
    Mol Cancer; 2010 Sep 09; 9():237. PubMed ID: 20828406
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS, Zheng YJ, Wang J, Zhao JY, Yang DK, Liu ZS.
    J Exp Clin Cancer Res; 2019 Feb 21; 38(1):97. PubMed ID: 30791932
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
    Liu N, He QM, Chen JW, Li YQ, Xu YF, Ren XY, Sun Y, Mai HQ, Shao JY, Jia WH, Kang TB, Zeng MS, Ma J.
    Mol Cancer; 2014 May 19; 13():111. PubMed ID: 24884612
    [Abstract] [Full Text] [Related]

  • 19. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
    Pan Y, Wang S, Su B, Zhou F, Zhang R, Xu T, Zhang R, Leventaki V, Drakos E, Liu W, Claret FX.
    Oncogene; 2017 Feb 23; 36(8):1069-1079. PubMed ID: 27524414
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.